Relations (1)

cross_type 0.10 — supporting 1 fact

Ketamine is recognized as a prescriptible treatment for treatment-resistant depression in Israel, as established by the clinical evidence cited in [1].

Facts (1)

Sources
Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com Springer 1 fact
claimKetamine is a prescriptible treatment for treatment-resistant depression (TRD) in the USA and Israel, with many other countries implementing this treatment, according to Mathai et al. (2020).